AIDS Therapies
Diketo Acids May Be New Candidate for HIV Therapy
Published in AIDS Weekly, February 7th, 2000
Existing drugs stop the virus from reproducing itself inside an infected cell by deactivating 2 of the virus' enzymes called reverse transcriptase and protease. But some strains of HIV have evolved to be resistant to these drugs.
In the January 28, 2000, issue of Science, D. J. Hazuda and colleagues at Merck Research Laboratories, West Point, Pennsylvania, reported they have targeted a third enzyme, called integrase, that is critical for the virus' ability to slip its DNA into the host cell's...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2000-02-07)
More Articles from AIDS Weekly
- Pathogenesis
Discovery of HIV Shedding Patterns and Viral Site Has Implications for AIDS Vaccines, Treatments - AIDS Therapies
Abundant Intracellular Zidovudine Triphosphate Found in Cord Blood - AIDS Therapies
Expanding Use of Potent HIV Therapies Will Limit Infections and AIDS Deaths, New Model Shows - Antiangiogenesis
Vinblastine Is Effective at Non-Toxic Doses - Chancroid (Treatment)
Ciprofloxacin Is An Effective Single-Dose Treatment - Epidemiology
The Road from SIV to HIV and the AIDS Epidemic - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
